Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julian S. Gangolli currently holds 71,169 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julian S. Gangolli has been a net seller of RVNC stock. They have purchased $0 and sold $27.4M worth of shares.
Julian S. Gangolli's most recent insider trade was on Oct 1, 2024, when they sold 71,169 shares at $0.00 per share.
Julian S. Gangolli serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 66 insider transactions totaling $27.4M over their tenure at the company.
Julian S. Gangolli holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Julian S. Gangolli has shown a selling trading pattern, with $0 in total purchases and $27.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Julian S. Gangolli was on Dec 27, 2013, when they sold $4.1M worth of AGN shares. This transaction involved 37,500 shares at $110.00 per share.
Julian S. Gangolli currently owns 71,169 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julian S. Gangolli's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julian S. Gangolli has 66 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Julian S. Gangolli and 40,000+ other insiders.